On Feb. 24, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…
On Feb. 22, 2023, the Centers for Disease Control and Prevention (CDC) reported that the 2022-2023 flu vaccines…
On Feb. 20, 2023, results from a randomized clinical trial of Ivermectin in a higher-hose and longer duration…
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
On Feb. 15, 2023, Moderna announced it will continue to offer its COVID-19 vaccines for free, even after…
On Feb. 13, 2023, Novavax announced a modification to its existing agreement with the U.S. Department of Health…
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
On Jan. 26, 2023, Centers for Disease Control and Prevention (CDC) reported that U.S. household spread of flu…
On Jan. 25, 2023, researchers at Oregon Health & Science University (OHSU) reported that Immunity from COVID-19 appears…
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
On Jan. 17, 2023, the Montana Fish and Wildlife Commission (FWP) reported that juvenile grizzly bears tested positive…
On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
On Jan. 10, 2023, the U.S. National Institutes of Health (NIH) reported that antiviral treatments can help reduce…
On Jan. 5, 2023, Novavax announced that Spain’s Public Health Commission, Italy’s Ministry of Health, and France’s Haute…
On Jan. 1, 2023, a study published in the Lancet reported that concentrations of antibiotic residues found in…
On Dec. 21, 2022, Moderna announced the the finalization of a strategic partnership with the United Kingdom (UK)…
On Nov. 12, 2022, the World Health Organization (WHO) issued a Disease Outbreak News (DON) on the circulating…
On Dec. 16, 2022, Novavax announced that the Standing Committee on Vaccination (STIKO) in Germany had expanded its…
On Dec. 16, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
On Dec. 12, 2022, the Oregon Department of Agriculture and the U.S. Department of Agriculture’s Animal Plant Health…
On Dec. 13, 2022, Texas Biomed announced that it had been designated as a prime contractor by the…
On Dec. 11, 2022, Novavax announced that the Switzerland’s Federal Office of Public Health and Francees Haute Autorite…
On Dec. 9, 2022, the World Health Organization (WHO) announced that the first doses of one of the…
On Dec. 8, 2022, Moderna announced it had received emergency use authorization from the U.S. Food and Drug…
On Dec. 5, 2022, the Fred Hutchinson Cancer Center announced that according to a new meta-analysis women were…
On Nov. 29, 2022, Novavax announced that the World Health Organization had issued an updated Emergency Use Listing…
On Nov. 27, 2022, it was reported a parasite that infects up to one-third of people around the…